KENS 5: Minorities are desperately needed for clinical trials

January 12, 2021

Dr. Barbara Taylor, Infectious Diseases, contributed to this second KENS 5 TV news segment on the Novavax trial launch, emphasizing that minorities are desperately needed for clinical trials because the inclusion of diverse groups in trials is the only way to make effective vaccines for all. Read and watch the story. 




MSN.com: City prepares for mass vaccinations | Here’s what you should know

January 11, 2021

Dr. Robert Leverence, chief medical officer for UT Health Physicians, contributed to a KENS 5 story that was propagated by MSN regarding helpful information as our city prepares for mass vaccinations, as well as on the topic of someone’s getting COVID between the administration of the first and second doses of the vaccine. Read and […]



UPI: Experts: More research needed to assess long-term effects of COVID-19 on brain

January 11, 2021

Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed by UPI‘s Brian Dunleavy regarding an article recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; the article cites decades of scientific evidence suggesting it is very likely that COVID-19 will have long-term effects on the brains and […]